Education
About Us
Working with TipRanks
Follow Us
Paradigm Biopharmaceuticals Ltd. (PBIGF)
OTHER OTC:PBIGF
PBIGF Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PBIGF Stock 12 Month Forecast
Average Price Target
$0.43
▲(95.45% Upside)
| Highest Price Target$0.43 | Average Price Target$0.43 | Lowest Price Target$0.43 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bell Potter
$0.48→$0.43
Buy
95.43%
Upside
Reiterated
09/30/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bell Potter
$0.48→$0.43
Buy
95.43%
Upside
Reiterated
09/30/25
Best Analysts Covering Paradigm Biopharmaceuticals
1 Month
xxx
Success Rate
6/9 ratings generated profit
Average Return
+8.74%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +8.74% per trade.
3 Months
xxx
Success Rate
5/9 ratings generated profit
Average Return
+5.43%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of +5.43% per trade.
1 Year
Success Rate
2/9 ratings generated profit
Average Return
-27.40%
reiterated a buy rating 3 months ago
Copying John Hester's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -27.40% per trade.
2 Years
xxx
Success Rate
2/9 ratings generated profit
Average Return
-50.96%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 22.22% of your transactions generating a profit, with an average return of -50.96% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PBIGF Analyst Recommendation Trends
Rating
Apr 23
Feb 25
Apr 25
Jul 25
Sep 25
Strong Buy
3
3
2
2
2
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
2
2
2
Strong Sell
0
0
0
0
0
total
3
3
4
4
4
Each month's total comprises the sum of three months' worth of ratings.
PBIGF Financial Forecast
PBIGF Stock Forecast FAQ
What is PBIGF’s average 12-month price target, according to analysts?
Based on analyst ratings, Paradigm Biopharmaceuticals Ltd.’s 12-month average price target is 0.43.
What is PBIGF’s upside potential, based on the analysts’ average price target?
Paradigm Biopharmaceuticals Ltd. has 95.45% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PBIGF a Buy, Sell or Hold?
Paradigm Biopharmaceuticals Ltd. has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Paradigm Biopharmaceuticals Ltd.’s price target?
The average price target for Paradigm Biopharmaceuticals Ltd. is 0.43. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $0.43 ,the lowest forecast is $0.43. The average price target represents 95.45% Increase from the current price of $0.22.
The highest analyst price target is $0.43 ,the lowest forecast is $0.43. The average price target represents 95.45% Increase from the current price of $0.22.
What do analysts say about Paradigm Biopharmaceuticals Ltd.?
Paradigm Biopharmaceuticals Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of PBIGF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.